Last reviewed · How we verify
NCT04111354: EMAPI
Early Mobilization After Pacemaker Implantation.
NA trial testing Pacemaker implantation in Pacemaker Complication in 200 participants. Completed in 31 August 2024.
31 August 2024
Quick facts
| Lead sponsor | Charles University, Czech Republic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 28 March 2019 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Pacemaker implantation
Conditions studied
- Pacemaker Complication — all drugs for Pacemaker Complication →
- Mobilization — all drugs for Mobilization →
Sponsor
Charles University, Czech Republic
Who can join
18 and older, any sex, with Pacemaker Complication or Mobilization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Permanent pacemaker implantation is one of the most common arrhythmological procedure. This procedure is usually accompanied by a minimum of 2-3 days hospitalization, with immobilization of patients (supine) for 16-24 hours. The optimal duration of patient´s immobilization is not determined. There is also no recommendation from individual manufacturers of pacemakers for the duration of immobilization after pacemaker implantation. The length of immobilization is based rather on the tradition established at the time of using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI) is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours) immobilization after primary pacemaker implantation. Septal position will be used for right ventricular electrode.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04111354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pacemaker implantation
Trials testing the same drug.
- NCT05774262 — Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block · NA · recruiting
- NCT05021627 — Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia · NA · not yet recruiting
- NCT04559646 — Application of the "Haemoblock" in Pacemaker Patients · completed
Other recruiting trials for Pacemaker Complication
Currently open trials in the same condition.
- NCT06355115 — Prophylactic Antibiotics Duration Towards Healing and Risk of Infection in Permanent Pacemaker (PPM) Installation · Phase 2 · recruiting
- NCT05390216 — Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic · NA · active not recruiting
- NCT03475498 — A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome) · recruiting
Other Charles University, Czech Republic trials
Trials by the same sponsor.
- NCT07475481 — Exercise-Based Strategies for Chronic Back Pain · NA · not yet recruiting
- NCT07468318 — Multimodal Therapy for Somatosensory Tinnitus · NA · not yet recruiting
- NCT07525154 — Development of a Certified Testing Procedure for Hip and Groin Injuries in Athletes · NA · not yet recruiting
- NCT07512570 — Feasibility and Preliminary Effects of a Structured Resistance Training Program in Children Aged 10-14 Years · NA · not yet recruiting
- NCT07424326 — Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04111354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charles University, Czech Republic
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04111354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing